293 related articles for article (PubMed ID: 28886999)
21. Macrocyclic α helical peptide therapeutic modality: A perspective of learnings and challenges.
Sawyer TK; Partridge AW; Kaan HYK; Juang YC; Lim S; Johannes C; Yuen TY; Verma C; Kannan S; Aronica P; Tan YS; Sherborne B; Ha S; Hochman J; Chen S; Surdi L; Peier A; Sauvagnat B; Dandliker PJ; Brown CJ; Ng S; Ferrer F; Lane DP
Bioorg Med Chem; 2018 Jun; 26(10):2807-2815. PubMed ID: 29598901
[TBL] [Abstract][Full Text] [Related]
22. Marine Depsipeptides as Promising Pharmacotherapeutic Agents.
Rangel M; de Santana CJ; Pinheiro A; Dos Anjos L; Barth T; Pires OR; Fontes W; Castro MS
Curr Protein Pept Sci; 2017; 18(1):72-91. PubMed ID: 27226199
[TBL] [Abstract][Full Text] [Related]
23. Depsipeptide synthesis.
Stawikowski M; Cudic P
Methods Mol Biol; 2007; 386():321-39. PubMed ID: 18604953
[TBL] [Abstract][Full Text] [Related]
24. Peptide Display Technologies.
Pitt A; Nims Z
Methods Mol Biol; 2019; 2001():285-298. PubMed ID: 31134576
[TBL] [Abstract][Full Text] [Related]
25. Protein epitope mimetic macrocycles as biopharmaceuticals.
Luther A; Moehle K; Chevalier E; Dale G; Obrecht D
Curr Opin Chem Biol; 2017 Jun; 38():45-51. PubMed ID: 28319811
[TBL] [Abstract][Full Text] [Related]
26. Development of novel antibacterial drugs to combat multiple resistant organisms.
Bassetti M; Righi E
Langenbecks Arch Surg; 2015 Feb; 400(2):153-65. PubMed ID: 25667169
[TBL] [Abstract][Full Text] [Related]
27. New bioactive macrocyclic diterpenoids from Jatropha multifida.
Kanth BS; Kumar AS; Shinde DB; Babu KH; Raju TV; Kumar CG; Sujitha P; Das B
Bioorg Med Chem Lett; 2011 Nov; 21(22):6808-10. PubMed ID: 21996519
[TBL] [Abstract][Full Text] [Related]
28. Conformational Strain of Macrocyclic Peptides in Ligand-Receptor Complexes Based on Advanced Refinement of Bound-State Conformers.
Brueckner AC; Deng Q; Cleves AE; Lesburg CA; Alvarez JC; Reibarkh MY; Sherer EC; Jain AN
J Med Chem; 2021 Mar; 64(6):3282-3298. PubMed ID: 33724820
[TBL] [Abstract][Full Text] [Related]
29. Macrocycles, the edge of drug-likeness chemical space or Goldilocks zone?
Selwood DL
Chem Biol Drug Des; 2017 Feb; 89(2):164-168. PubMed ID: 28205398
[No Abstract] [Full Text] [Related]
30. Drug discovery strategies to outer membrane targets in Gram-negative pathogens.
Brown DG
Bioorg Med Chem; 2016 Dec; 24(24):6320-6331. PubMed ID: 27178386
[TBL] [Abstract][Full Text] [Related]
31. New Found Hope for Antibiotic Discovery: Lipid II Inhibitors.
Ng V; Chan WC
Chemistry; 2016 Aug; 22(36):12606-16. PubMed ID: 27388768
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, spectral studies and antibacterial activity of novel macrocyclic Co(II) compounds.
Reddy PM; Prasad AV; Shanker K; Ravinder V
Spectrochim Acta A Mol Biomol Spectrosc; 2007 Nov; 68(3):1000-6. PubMed ID: 17553737
[TBL] [Abstract][Full Text] [Related]
33. Cyclic lipodepsipeptides: a new class of antibacterial agents in the battle against resistant bacteria.
Bionda N; Pitteloud JP; Cudic P
Future Med Chem; 2013 Jul; 5(11):1311-30. PubMed ID: 23859209
[TBL] [Abstract][Full Text] [Related]
34. Structure-based design of a macrocyclic inhibitor for peptide deformylase.
Hu X; Nguyen KT; Verlinde CL; Hol WG; Pei D
J Med Chem; 2003 Aug; 46(18):3771-4. PubMed ID: 12930137
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and antibacterial evaluation of macrocyclic diarylheptanoid derivatives.
Lin H; Bruhn DF; Maddox MM; Singh AP; Lee RE; Sun D
Bioorg Med Chem Lett; 2016 Aug; 26(16):4070-6. PubMed ID: 27406794
[TBL] [Abstract][Full Text] [Related]
36. Modular Synthesis of Diverse Natural Product-Like Macrocycles: Discovery of Hits with Antimycobacterial Activity.
Dow M; Marchetti F; Abrahams KA; Vaz L; Besra GS; Warriner S; Nelson A
Chemistry; 2017 May; 23(30):7207-7211. PubMed ID: 28374952
[TBL] [Abstract][Full Text] [Related]
37. A Versatile Approach to Noncanonical, Dynamic Covalent Single- and Multi-Loop Peptide Macrocycles for Enhancing Antimicrobial Activity.
Reuther JF; Goodrich AC; Escamilla PR; Lu TA; Del Rio V; Davies BW; Anslyn EV
J Am Chem Soc; 2018 Mar; 140(10):3768-3774. PubMed ID: 29466660
[TBL] [Abstract][Full Text] [Related]
38. Chemistry. Rings of destruction.
Ganz T
Nature; 2001 Jul; 412(6845):392-3. PubMed ID: 11473296
[No Abstract] [Full Text] [Related]
39. Targeting biofilms and persisters of ESKAPE pathogens with P14KanS, a kanamycin peptide conjugate.
Mohamed MF; Brezden A; Mohammad H; Chmielewski J; Seleem MN
Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):848-859. PubMed ID: 28132897
[TBL] [Abstract][Full Text] [Related]
40. Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S.
Lee DL; Hodges RS
Biopolymers; 2003; 71(1):28-48. PubMed ID: 12712499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
